Fill in the form below and our experts will get back to you within 1 business day.
CD Biosynsis engineers microbial production platforms for high-value cosmetic ingredients. From bioactive peptides to natural pigments, we deliver sustainable, clean-label actives that meet consumer demands for natural beauty products.
Serving the Cosmetics & Personal Care Industry
Cosmetic Brands
Clean beauty product developers
Ingredient Suppliers
Bio-active cosmetic manufacturers
Contract Manufacturers
Cosmetic formulation partners
Spas & Wellness
Professional skincare products
End-to-end capabilities for bioactive cosmetic compound production
Anti-aging and skin-repair peptide production
Carotenoids, betalains, and anthocyanins
Biosurfactants and mild cleansing agents
Natural antimicrobial compounds
The cosmetics industry faces pressure for sustainable sourcing, clean labels, and consistent efficacy. Our platform addresses these through precision fermentation of natural-origin ingredients.
Consumers demand sustainably sourced ingredients, but plant extraction faces land use, seasonal variability, and supply constraints. Microbial fermentation provides consistent, scalable alternatives.
Traceability requirements intensify as consumers demand ingredient transparency. Engineered microorganisms enable complete supply chain visibility from gene to final product.
Natural ingredients vary in potency due to source variability. Microbial fermentation enables standardized bioactive concentrations ensuring batch-to-batch consistency.
Platform Approach
40% faster development
We engineer microbial cell factories for cosmetic ingredient production. Our platform enables clean-label, sustainable alternatives to traditional sourcing while maintaining or exceeding the efficacy of conventional beauty actives.
Design and optimize microbial expression for cosmetic peptides including collagen-stimulating, antioxidant, and anti-inflammatory sequences.
Engineer microbial pathways for carotenoids (astaxanthin, beta-carotene) and plant-derived colorants independent of agricultural variables.
Develop sophorolipid, rhamnolipid, and mannosylerythritol lipid platforms for mild, biodegradable cleansing ingredients.
Engineer strains for coenzyme Q10, ferulic acid, and polyphenol precursors that protect skin from oxidative stress and environmental damage.
Microbial production of aromatic compounds including rose-like phenylethyl alcohol and floral esters as sustainable fragrance alternatives.
Engineer natural antimicrobial peptides and organic acid pathways as alternatives to synthetic preservatives for clean-label cosmetics.
Why the cosmetics industry is adopting synthetic biology for ingredient supply
| Parameter | Chemical Inputs | Synthetic Biology |
|---|---|---|
| Source Variability | Plant extracts vary by season and geography | Consistent production year-round |
| Supply Capacity | Limited by agricultural land and yields | Scalable fermentation independent of land |
| Chemical Purity | Variable active concentrations in mixtures | Defined compounds with consistent potency |
| Carbon Footprint | Transportation, land use, water consumption | Controlled fermentation with optimization |
| Animal Testing | Many ingredients historically required testing | Non-animal, cruelty-free production |
Integrated molecular biology and analytical capabilities for cosmetic bioactive production.
Recombinant peptide synthesis with sequence optimization and folding control
Metabolic engineering for complex secondary metabolite biosynthesis
Scalable production from bench to commercial manufacturing
Active compound compatibility and stability in final formulations
We function as your external strain engineering and metabolic pathway team. Whether you need a single engineered chassis or a complete pathway optimization pipeline, we deliver publication-quality data and transfer-ready strains.
Each project is assigned a dedicated PhD-level scientist as primary contact, ensuring technical continuity and rapid decision-making throughout development.
Engage us for full end-to-end development or specific phases (strain engineering only, fermentation optimization only, etc.). Scale investment according to your validation needs.
All proprietary strains and sequences remain your exclusive property. We offer clean IP transfer with no residual license claims or downstream revenue sharing requirements.
In-house regulatory affairs team experienced with FDA MoCRA, EU Cosmetics Regulation, and INCI guidelines. We prepare submission-ready dossiers for your target markets.
Concept to pilot validation. Includes strain engineering, fermentation optimization, and greenhouse testing.
Genetic modification and characterization. Deliverables include sequence-confirmed strains and technical reports.
Process development and optimization. From lab-scale proof to pilot-scale production parameters.
Characterization, stability testing, and regulatory dossier preparation for submission.
Get answers to common questions about our cosmetic ingredient solutions. our team for project-specific inquiries.
Yes, we work with client-specified peptide sequences and can perform de novo design based on target activities such as collagen stimulation, tyrosinase inhibition, or barrier repair.
Ingredients typically fall under INCI requirements. We provide documentation packages including strain construction history, production process, purity specifications, and safety data for global submissions.
We provide process development through pilot scale (100-1000L) and facilitate technology transfer to GMP contract manufacturers for commercial production.
Peptides typically achieve 100-500 mg/L. Carotenoids achieve 1-5 g/L. Yield targets are established during feasibility assessment and optimized as part of development campaigns.
Regulatory classification depends on your final product and modification approach. We can engineer strains using methods that may qualify for streamlined review (e.g., self-cloning, site-directed mutagenesis). Our regulatory team provides guidance on INCI Name Registration, EU Cosmetics Regulation (EC) No 1223/2009, and FDA MoCRA requirements during the project design phase to ensure your strain aligns with your intended regulatory pathway.
Get a customized quote for your Cosmetics project. Our experts will respond within 24 hours.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.